medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2013, Número 3

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2013; 11 (3)


Escabiosis: una revisión

Plascencia GA, Proy TH, Eljure LN, Atoche DC, Calderón RC

Idioma: Español
Referencias bibliográficas: 35
Paginas: 217-223
Archivo PDF: 255.60 Kb.


RESUMEN

Escabiosis es una enfermedad cosmopolita, contagiosa y pruriginosa que se observa, sobre todo, en menores de 5 años durante la época invernal, y se transmite de persona a persona en lugares hacinados, como asilos u orfanatos. El diagnóstico estriba en la detección del agente causal mediante raspado de piel y el tratamiento se fundamenta en medicamentos tópicos y sistémicos. El pronóstico es favorable si se trata correctamente.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Chosidow O. “Scabies”. N England J Med 2006; 354: 1718-1726.

  2. Stanton B, Khanam S, Nazrul H, et al. “Scabies in urban Bangladesh”. J Trop Med Hyg 1987; 90: 219-226.

  3. Jackson A, Heukelbach J, Filho AF, et al. “Clinical features and associated morbidity of scabies in a rural community in Alagoas, Brazil”. Trop Med Int Health 2007; 12: 493-502.

  4. Mahé A. “Bacterial skin infections in a tropical environment”. Curr Opin Infect Dis 2001; 14: 123-126.

  5. Feldmeier H, Chhatwal GS, Guerra H. “Pyoderma, group A streptococci and parasitic skin diseases – a dangerous relationship”. Trop Med Int Health 2005; 10: 713-716.

  6. Sistema Nacional de Vigilancia Epidemiológica. Sistema Unico de Información de Vigilancia Epidemiológica núm 30, vol 27.

  7. Galván Pérez JI. “Historia de la sarna”. Piel 2004; 19: 533-537.

  8. Airlan LG, Runyan RA, Achar S, Estes SA. “Survival and infectivity of Sarcoptes scabiei var canis and var. hominis”. J Am Acad Dermatol 1984; 11: 210-215.

  9. Shmidt E, Levitt J. “Dermatologic infestations”. International Journal of Dermatology 2012; 51: 131-141.

  10. Worth C, Huekelbach J, Fengler G, Walter B, Liesenfeld O, Hengee U, et al. “Acute morbidity associated with scabies and other ectoparasitoses rapidly improves after treatment with invermectin”. Pediatric Dermatology 2012; 29: 430-436.

  11. Steen CJ, Carbonaro PA, Schwarts RA. “Arthropods in dermatology”. J Am Acad Dermatol 2004; 50: 819-842.

  12. Hengge UR, Currie BJ, Lupi O, Schwarts RA. “Scabies: a ubiquitous neglected skin disease”. Lancet infect Dis 2006: 12: 769-779.

  13. Fischer K, Holt DC, Harumal P, Currie BJ, Walton SF, Kemp DJ. “Generation and characterization of cDNA clones from Sarcoptes scabiei var hominis for an expressed sequence tag library:identification of homologues of house dust mite allergens”. Am J Trop Med Hyg 2003; 68: 61-64.

  14. Sun G, Stacey MA, Schmidt M, Mori L, Mattoli S. “Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells”. J Immunol 2001; 167: 1014-1021.

  15. Mellanby K. “The development of symptoms, parasitic infection and immunity in human scabies”. Parasitology 1944, 35: 197-206.

  16. Chosidow O. “Scabies and pediculosis”. Lancet 2000; 355: 819-826.

  17. Paucar K, Del Solar M, Bravo F, Salomon M, Puell L, Feria K, et al. “Sarna costrosa”. Folia Dermatol Peúru 2010; 21: 101-104.

  18. Blas M, Bravo F, Castillo W, Ballona R, Navarro P, Catacora J. et al. “Norweigan scabies in Peru: The impact of human T cell lymphotropic virus type I infection”. Am J Trop Med Hyg. 2005 72: 855-857.

  19. Roberts LJ, Huff am SE, Walton SF, Currie BJ. “Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature”. J Infect 2005; 50: 375-381.

  20. Barnhill RL. Dermatopatholy. 3 ed. Mc GrawHill 2010: 75-76.

  21. Park JH, Kim CW, Kim SS. “The diagnostic accuracy of dermoscopy for scabies”. Ann Dermatol 2012; 24: 194-199.

  22. Van der Heijden HM, Rambags PG, Elbers AR, Van Maanen C, Hunneman WA. “Validation of ELISAs for the detection of antibodies to Sarcoptes scabiei in pigs”. Vet Parasitol 2000; 89: 95-107.

  23. Monsel G, Chosidow O. “Management of Scabies”. Skin Therapy Lett 2012; 17: 1-4.

  24. Norihisa I, Akihiko A, Amagai M, Iijima M, Ishikawa O, Imamura H. “Guideline for the diagnosis and treatment of scabies in Japan”. Journal of Dermatology 2008; 35: 378-393.

  25. Johnstone SM. “Interventions for treating Scabies (review)”. Cochrane Database Syst Rev 2011; 6: 1790-1862.

  26. Lenne PA. “Scabies and pediculosis pubis: An update of treatment regimens and general review”. Clin Infect Dis 2007; 1; 44(Suppl 3): S153-S159.

  27. Pruksachatkunakorn C, Damrongsak M, Sinthupuan RN. “Sulfur for Scabies Outbreaks in Orphanages”. Pediatric Dermatology 2002; 19: 448-453.

  28. Usha V, Gopalak TV. “A comparative study of oral ivermectina and topical permethrin cream in the treatment of scabies”. J Am Acad Dermatol 2000; 42: 236-240.

  29. Albakri L, Goldman R. “Permethrin for scabies in children”. Can Fam Physician. 2010; 56: 1005-1006.

  30. Chhaiya SB, Patel VJ, Dave JN, Mehta DS, Shah HA. “Comparative efficacy and safety of topical permethrin, topical invermectin, and oral ivermectin in patients of uncomplicaded scabies”. Indian J Dermatol Venereol Leprol 2012; 78: 605-610.

  31. Hay RJ, Steer AC, Engelman D, Walton S. “Scabies in the developing world – its prevalence, complications and management”. Clin Microbiol Infect 2012; 18: 313-323.

  32. Goldust M, Rezaee E, Hemayat S. “Treatment of scabies: Comparison of permethrin 5% versus invermectin”. J Dermatol 2012; 39: 545-547.

  33. Sharma R, Singal A. “Topical permethrin and oral ivermectina in the management of scabies: a prospective, randomized, double blind, controlled study”. Indian J Dermatol Venereol Leprol 2011; 77: 581-586.

  34. Caumes E, Ndaw CA, Ndiaye B, Mahe A. “Ivermectina versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial”. Bull WHO 2009; 87: 424-430.

  35. Arenas R. Dermatología. Atlas, diagnóstico y tratamiento. 4ed. México, Mc Graw-Hill 2009: 538-544.




2020     |     www.medigraphic.com